Global biologics safety testing market size to expand significantly through 2026

The research report on the ‘global biologics safety testing market’ delivers comprehensive analysis of the growth trends, challenges & restraints, and other expansion avenues which are impacting the growth matrix and the revenue prospects of this business vertical.


Selbyville, Delaware, April 27, 2021 (GLOBE NEWSWIRE) -- Analysts cite that global biologics safety testing market size had reached a valuation of USD 3463.90 million in 2020 and is likely to showcase a robust compound annual growth rate over the period of 2021-2026. This growth is primarily driven by flourishing biotechnology and pharmaceutical sectors, favorable regulatory outlook, and surging investments towards research and development.

Moreover, the document talks about the several market segmentations such as product type, application scope, and test type. Critical insights pertaining to the geographical reach and the competitive scenario of this market space is also scrutinized and provided in the study.

High preferences towards pharmaceutical outsourcing along with growing demand for biologics are also stimulating global biologics safety testing industry outlook. Increasing number of pipeline drugs and rising prevalence of chronic conditions are also providing lucrative growth opportunities for the industry participants.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3578559/

Speaking of which, the race to produce therapeutically advanced drugs has compelled the leading companies to enhance their manufacturing capabilities as well as focus towards cost-efficiency and productivity, which in turn is adding traction to the overall market size.

Strict government regulations regarding biologics safety testing kits and high costs associated with the product could, however, act as a restraining factor to the growth of the market. Regardless, several governments are lately emphasizing towards deploying relevant standards for biological safety, which in turn could potentially fuel global biologics safety testing industry share.

An overview of the market segmentations

The product landscape of global biologics safety testing industry is segmented into services, instruments, and high kits & reagents.

Estimates claim that high kits & reagents captured the largest market share and is likely to depict similar growth trends in the subsequent years, owing to the proliferating sales of the product as compared to its counterparts.

The application scope of this business space includes gene therapy, blood & blood based products, vaccine & therapeutics, and others. By test type, the market is bifurcated into adventitious agent detection tests, sterility test, bioburde test, endotoxin tests, and others.

A summary of the geographical reach

Global scope of operations of this business domain includes regions such as North America, Asia-Pacific, and Europe. The country-level bifurcation includes Canada, United States, India, China, Japan, Germany, Italy, United Kingdom, and France among others.

In terms of revenue, North America held the largest share in global biologics safety testing industry in the year 2020 and is expected to register continuous growth during the study duration.

Rising R&D activities, rapid expansion of the pharmaceutical sector, escalating investments in biotechnology, and widespread adoption of biologics safety testing kits are swaying the business dynamics in North America.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-biologics-safety-testing-market-analysis-by-product-test-application-by-region-by-country-2021-edition-market-insights-covid-19-impact-competition-and-forecast-2021-2026

Global Biologics Safety Testing Market Product Varieties (Revenue, USD Million, 2016-2026)

  • Services
  • Instruments
  • High Kits & Reagents

Global Biologics Safety Testing Market Application Spectrum (Revenue, USD Million, 2016-2026)

  • Gene Therapy
  • Blood & Blood Based Products
  • Vaccine & Therapeutics
  • Others

Global Biologics Safety Testing Market by Test (Revenue, USD Million, 2016-2026)

  • Adventitious Agent Detection Tests
  • Sterility Tests
  • Bioburde Tests
  • Endotoxin Tests
  • Others

Global Biologics Safety Testing Market Geographical Landscape (Revenue, USD Million, 2016-2026)

North America

  • Canada
  • United States

Europe

  • Germany
  • United Kingdom
  • France
  • Italy

Asia-Pacific

  • India
  • South Korea
  • China
  • Japan

Global Biologics Safety Testing Market by Competitive Scenario (Revenue, USD Million, 2016-2026)

  • Eurofins Scientific
  • WuXi AppTec
  • Maravai Life Sciences Inc.
  • Charles River Laboratories Inc.
  • Samsung Biologics
  • Thermo Fisher Scientific Inc.
  • The Merck Group
  • Sartorius AG
  • SGS S.A.
  • Lonza Group AG

Table of Content:

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology 

1.3 Executive Summary

2. Strategic Recommendations

3. Biologics Safety Testing Market: Product Overview

4. Global Biologics Safety Testing Market: Sizing and Forecast

4.1 Market Size, By Value, Year 2016-2026

4.2 Impact of COVID-19 on Biologics Safety Testing Market 

5. Global Biologics Safety Testing Market; An Analysis (2021-2026)

5.1  Competitive Scenario of Global Biologics Safety Testing Market: By Product

5.1.1 High Kits & Reagents ?? Market Size and Forecast (2016-2026) 

5.1.2 Instruments - Market Size and Forecast (2016-2026)

5.1.3 Services ?? Market Size and Forecast (2016-2026) 

5.2 Competitive Scenario of Global Biologics Safety Testing Market: By Application 

5.2.1 Vaccine & Therapeutics ?? Market Size and Forecast (2016-2026) 

5.2.2 Blood & Blood Based Products ?? Market Size and Forecast (2016-2026) 

5.2.3 Gene Therapy - Market Size and Forecast (2016-2026) 

5.2.4 Others ?? Market Size and Forecast (2016-2026) 

5.3 Competitive Scenario of Biologics safety testing Market: By Test                      

5.3.1 Endotoxin Tests - Market Size and Forecast (2016-2026) 

5.3.2 Sterility Tests - Market Size and Forecast (2016-2026) 

5.3.3 Bioburde Tests ??-Market Size and Forecast (2016-2026) 

5.3.4 Adventitious Agent Detection Tests ?? Market Size and Forecast (2016-2026) 

5.3.5 Others ?? Market Size and Forecast (2016-2026) 

6. Global Biologics safety testing Market: Regional Analysis

6.1 Competitive Scenario of Global Biologics safety testing Market: By Region 

7. North America Biologics safety testing Market: An Analysis (2021-2026) 

7.1 North America Biologics safety testing Market : Size and Forecast (2016-2026), By Value 

7.2 North America Biologics safety testing Market ?? Prominent Companies 

7.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)                                                 

7.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others) 

7.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburde Tests, Adventitious Agent Detection Tests  and Others) 

8. Europe Biologics safety testing Market: An Analysis (2021-2026) 

8.1 Europe Biologics safety testing Market : Size and Forecast (2016-2026), By Value 

8.2 Europe Biologics safety testing Market ?? Prominent Companies 

8.3 Market Segmentation By Product Type (High Kits & Reagents, Instruments and Services)                                                 

8.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy, Others) 

8.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests, Others) 

9. Asia Pacific Biologics safety testing Market: An Analysis (2021-2026) 

9.1 Asia Pacific Biologics safety testing Market : Size and Forecast (2016-2026), By Value

9.2 Asia Pacific Biologics safety testing Market ?? Prominent Companies

9.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)                                                  

9.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others)

9.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests  and Others)

10. Global Biologics safety testing Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Trends

11. Market Attractiveness

11.1 Market Attractiveness Chart of Global Biologics safety testing Market - By Product, 2026

11.2 Market Attractiveness Chart of Global Biologics safety testing Market - By Application, 2026

11.3 Market Attractiveness Chart of Global Biologics safety testing Market - By Test, 2026

11.4 Market Attractiveness Chart of Global Biologics safety testing Market - By Region, 2026

12. Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers

12.2 SWOT Analysis

12.3 Market Share Analysis

13. Regulatory Compliance

14. Company Profiles (Business Description, Financial Analysis, Business Strategy)


Related Report:

Biological Safety Testing Market, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Global Biological Safety Testing Market is expected to exceed USD 4.5 billion by 2025. Increasing implementation of biological safety testing for safe and microbe-free production of biologics and pharmaceutical products will propel market growth. Biological safety testing market will witness substantial growth owing to increasing risk of healthcare associated infections (HAIs) globally. Acquisition of blood-borne infections including pneumonia, after blood/blood-derived product transfusion may lead to severe morbidity or result into death. Hence, with growing application of blood-based products for surgeries and cosmetic applications along with need for minimizing the risk of HAIs, biological safety testing market will significantly expand over the upcoming years.


Stem cells market is projected to progress at robust pace over the analysis period. Burden of diseases including congenital disorders, arthritis as well as autoimmune diseases is rapidly growing across the globe. Stem cells and cell banks may have undesired burden of adventitious agents such as bacteria, viruses, protozoa among several others. Thus, these cell banks need to be free from adventitious agents to avoid proliferation of fatal infections. Thus, growing application of stem cells in regenerative medicine will thereby increase the demand for biological safety testing.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

 
 

Coordonnées